Moneta Group Investment Advisors LLC Gilead Sciences, Inc. Transaction History

Moneta Group Investment Advisors LLC

$5.03 Billion
Q4 2023

A detailed history of Moneta Group Investment Advisors LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Moneta Group Investment Advisors LLC holds 11,728 shares of GILD stock, worth $782,140. This represents 0.02% of its overall portfolio holdings.

Number of Shares

11,728

Previous 10,470 12.02%

Holding current value

$782,140

Previous $784,000 21.17%

% of portfolio

0.02%

Previous 0.02%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	BUY	$73.27 - $83.09 $92,173 - $104,527	1,258 Added 12.02%	11,728 $950,000
Q3 2023 Nov 15, 2023	BUY	$73.94 - $80.67 $25,139 - $27,427	340 Added 3.36%	10,470 $784,000
Q2 2023 Aug 15, 2023	SELL	$76.01 - $86.7 $66,432 - $75,775	-874 Reduced 7.94%	10,130 $780,000
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $57,595 - $65,619	745 Added 7.26%	11,004 $913,000
Q4 2022 Feb 16, 2023	BUY	$62.32 - $89.47 $9,223 - $13,241	148 Added 1.46%	10,259 $880,000

Q4 2022 Feb 16, 2023	SELL	$62.32 - $89.47 $629 Million - $904 Million	-10,101,083 Reduced 99.9%	10,111 $868,000
Q4 2022 Feb 15, 2023	BUY	$62.32 - $89.47 $629 Million - $904 Million	10,100,755 Added 96759.79%	10,111,194 $868 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $3,096 - $3,536	52 Added 0.5%	10,439 $644,000
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $18,932 - $21,323	-328 Reduced 3.06%	10,387 $642,000
Q1 2022 May 11, 2022	BUY	$57.92 - $72.58 $23,168 - $29,032	400 Added 3.88%	10,715 $637,000
Q4 2021 Feb 11, 2022	SELL	$64.88 - $73.64 $181,599 - $206,118	-2,799 Reduced 21.34%	10,315 $749,000
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $2.31 Million - $2.5 Million	-34,170 Reduced 72.27%	13,114 $916,000
Q2 2021 Aug 13, 2021	BUY	$63.47 - $69.35 $70,642 - $77,186	1,113 Added 2.41%	47,284 $3.26 Million
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $226,500 - $258,436	3,775 Added 8.9%	46,171 $2.98 Million
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $29,571 - $33,695	-522 Reduced 1.22%	42,396 $2.47 Million
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $45,084 - $56,686	-726 Reduced 1.66%	42,918 $2.71 Million
Q2 2020 Aug 12, 2020	BUY	$72.34 - $84.0 $60,765 - $70,560	840 Added 1.96%	43,644 $3.36 Million
Q1 2020 May 13, 2020	BUY	$62.63 - $80.22 $58,245 - $74,604	930 Added 2.22%	42,804 $3.2 Million
Q4 2019 Feb 11, 2020	SELL	$61.62 - $67.78 $271,251 - $298,367	-4,402 Reduced 9.51%	41,874 $2.72 Million
Q3 2019 Nov 12, 2019	SELL	$62.51 - $69.0 $292,921 - $323,334	-4,686 Reduced 9.2%	46,276 $2.93 Million
Q2 2019 Aug 16, 2019	BUY	$61.87 - $69.38 $2.65 Million - $2.97 Million	42,826 Added 526.38%	50,962 $3.44 Million
Q2 2019 Aug 13, 2019	SELL	$61.87 - $69.38 $2.09 Million - $2.34 Million	-33,781 Reduced 80.59%	8,136 $3.44 Million
Q1 2019 May 16, 2019	BUY	$62.53 - $70.05 $1.29 Million - $1.44 Million	20,613 Added 96.76%	41,917 $2.73 Million
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $1.43 Million - $1.6 Million	-22,885 Reduced 51.79%	21,304 $2.73 Million
Q4 2018 Feb 11, 2019	BUY	$60.54 - $79.0 $484 - $632	8 Added 0.02%	44,189 $2.76 Million
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $628,475 - $695,837	-8,817 Reduced 16.64%	44,181 $3.41 Million
Q2 2018 Aug 15, 2018	SELL	$64.88 - $75.68 $8.19 Million - $9.55 Million	-126,252 Reduced 70.43%	52,998 $3.75 Million
Q2 2018 Aug 15, 2018	SELL	$64.88 - $75.68 $620,447 - $723,727	-9,563 Reduced 5.06%	179,250 $3.75 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $9.33 Million - $10.9 Million	143,740 Added 318.9%	188,813 $4.13 Million
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $242,994 - $296,236	-3,336 Reduced 6.89%	45,073 $3.4 Million
Q4 2017 Feb 13, 2018	SELL	$71.15 - $83.52 $336,254 - $394,715	-4,726 Reduced 8.89%	48,409 $3.47 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $3.83 Million - $4.54 Million	53,135	53,135 $4.31 Million

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $83.6B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moneta Group Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moneta Group Investment Advisors LLC with notifications on news.

Account

Moneta Group Investment Advisors LLC Gilead Sciences, Inc. Transaction History